Here, we present an integrated strategy, SiaQuant, which contains the proteome-wide characterization and relative quantification of serum α2,3/α2,6 sialylation using liquid chromatography-ion mobility-tandem mass spectrometry (LC-IM-MS/MS) based on characteristic isomeric glycan features.